KDL MEDICAL: (1) PROPOSED ADOPTION OF THE 2023 SHARE INCENTIVE SCHEME; (2) PROPOSED CHANGE OF COMPANY NAME; (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (4) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE TO HANDLE MATTERS PERTAINING TO

HKEX · Oct 15, 2023 18:30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

康德萊醫械：（1）建議採納2023年股權激勵計劃；（2）建議更改公司名稱；（3）建議修訂《公司章程》；（4）建議授權董事會及/或授權人士辦理2023年股權激勵計劃相關事宜；及（5）2023年第一次股東特別大會通告

KDL MEDICAL: (1) PROPOSED ADOPTION OF THE 2023 SHARE INCENTIVE SCHEME; (2) PROPOSED CHANGE OF COMPANY NAME; (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (4) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE TO HANDLE MATTERS PERTAINING TO

Risk Disclaimer

Statement